← All trials
NCT03191084
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2017
- Primary completion
- Jun 30, 2018
- Completion date
- Jun 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Yale UniversityLead sponsor
- Yale UniversityReponsible party - principal investigator
- National Institute on Drug Abuse (NIDA)Collaborator
- University of ConnecticutCollaborator
- Maastricht UniversityCollaborator
- Montana State UniversityCollaborator
- NHTSACollaborator
- The Mind Research NetworkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.